Scientific area

Publications: 21

10 March 09 Programa Piloto de Preveciòn de Càncer de Colòn y Recto J. Cruzado Quevedo, F. Pérez Riquelme, E. Torrella Cortès, M. C. Cavas Martìnez, P. Esteban Garcìa, J. J. Gutiérrez Garcìa, e Grupo Investigaciòn PCaColon y Recto Experience and preliminary resuts of the pilot program for the prevention of Colorectal Cancer in the Salud VI area of the Spanish Region of Murcia. The Salud VI area covers 13 Zonas de Salud and 1 District Hospital for a total of 35.771 people.
24 February 09 Small Dense LDL-cholesterol: a superior diagnostic marker Yasuki Ito, Yosuke Meguro, Kunio Kamata, Tsutomu Hirano, Makoto Kinoshita, Mariko Shiba, Tetstuo Shoji, Shinji Koba, Akira Tanaka, Gen Yoshino Small dense LDL-cholesterol as a superior diagnostic marker for familial combined hyperlipidemia: sd LDL-C was mesured by s LDL-C'SEIKEN' using the heparin-magnesium precipitation method and mean LDL diameter was determined by the 2-16% gradient gel electrophoresis. Comparison of the sensitivity and specificity for discriminating familial combined hyperlipidemia (FCHL) from hyperlipidemia among four different parameters.
23 February 09 FOBT Common Guaiac vs. Immunochemical Test H. J. Roth, H. Schmidt-Gayk Fecal Occult Blood Test (FOBT) study: common guaiac versus immunochemical test. Higher sensitivity of the more recently developed iFOBTs simplifies and improves compliance in participation in the colon-rectal cancer (CRC) screening programs by thresholds adjustment versus sensitivity and specificity balance.
11 February 09 Comparison of CT colonography, colonoscopy, sigmoidoscopy and FOBT for adenoma detection A. Graser, P. Stieber, D. Nagel, C. Shafer, D. Horst, C. R. Becker, K. Nikolaou, A. Lottes, S. Geisbusch, H. Kramer, A. C. Wagner, H. Diepolder, J. Schirra, H. J. Roth, D. Seidel, B. Goke, M. F. Reiser, F. T. Kolligs Prospective trial for comparison of the performance characteristics of 5 different screening tests in parallel for the detection of advanced colonic neoplasia: CT colonography (CTC), colonoscopy (OT), flexible sigmoidoscopy (FS), faecal immunochemical stool testing (FIT) and faecal occult blood testing (FOBT).
09 January 09 Colorectal Cancer Screening By Quantitation Of Haemoglobin In Card C. M. Matthew, K. McKay, R. J. C. Steele, C. G. Fraser Screening for colonrectal cancer is increasing all over the world: guaiac faecal occult blood tests (gFOBT) are the most frequently used, while new faecal immunochemical tests (FIT) are now available for the quantitation of haemoglobin in faeces by collection in easy to use primary tubes.
16 September 08 Assessment of an Affinity Based Point of Care System for HbA1c A. Mosca, R. Paleari, G. Passerini, F. Ceriotti Evaluation of the analitical performance of a new Point of Care system (POCT) Afinion AS100 Analyzer (Axis-Shield PoC AS, Oslo, N), based on boronate affinity chromatography. The system takes 3 minutes per test, requires 1.5 μL whole blode per analysis, does not suffer interference in presence of HbS and HbC and reports National Glycohemoglobin Standardization Program (NGSP) aligned values.
09 September 08 Preliminary Evaluation of a new Cystatin C Assay on the ABBOTT Clinical Chemistry Systems R. Lucini, R. Dioli, L. De Angelis, F. Rota, M. Fritz, H. Troonen A new Cystatin C assay evaluation on the ABBOTT ARCHITECT cSystems and AEROSET Clinical Chemistry Systems.Verification of the analytical performance and agreement with the NACB's guidelines for Emerging Biomarkers of Cardiovascular Disease and Stroke.
09 September 08 Evaluation of SENTINEL CH. special assays on the ABBOTT c16000 Clinical Chemistry System R. Lucini, R. Dioli, E. Marelli, F. Rota, M. Fritz, H. Troonen Optimization of clinical laboratory workflow through consolidation of assays on a high-throughput analyzer as the recently introduced ABBOTT ARCHITECT c16000.
09 August 08 Evaluation of SENTINEL CH. Serum Protein Assays on Synchron LX Clinical Chemistry Sistem F. Rota, A. Mezzadra, R. Dioli Analytical performance of some SENTINEL CH. Protein assays where evaluated on the Beckman Coulter Syncron LX Clinical Chemistry System. Supporting the effort of clinical laboratories to consolidate all the Protein Panel on one unique instrument platform to maximize lab workflow. (Studies carried out in partnership with Beckman Coulter Inc.)
09 August 08 Evaluation of MULTIGENT Creatinine (Enzymatic) Liquid on the ABBOTT Clinical Chemistry Systems F. Rota, F.Magro, B. Nance, H. V. Markle Evaluation of the MULTIGENT Creatinine (Enzymatic) Liquid assay on the ABBOTT ARCHITECT c8000 and AEROSET Clinical Chemistry Systems. Verification of the analytical performance and agreement with the NKDEP recommendations.
1 2 3

Sentinel CH. SpA - Via Robert Koch, 2 - 20152 Milano
Phone 02.345514.1 - Fax 02.345514.64 - Email: sentinel@sentinel.it
REA: MI-1139796 - P.I.: 07118040158 - Cap.Soc. € 2.500.000,00 i.v.
Copyright© 2009 SENTINEL. All rights reserved.
versione italiana | disclaimer | credits

CERTIFIED QUALITY MANAGEMENT SYSTEM
ISO 9001:2008 - ISO 13485:2003 - ISO 13485:2003 CMDCAS
Compliant with the 21CFR820 "Code of Federal Regulations" FDA
IFCC Corporate MEMBER - IRMM Validated SUPPLIER

Scientific area

Programa Piloto de Preveciòn de Càncer de Colòn y Recto

Small Dense LDL-cholesterol: a superior diagnostic marker

FOBT Common Guaiac vs. Immunochemical Test

Comparison of CT colonography, colonoscopy, sigmoidoscopy and FOBT for adenoma detection

Colorectal Cancer Screening By Quantitation Of Haemoglobin In Card

Assessment of an Affinity Based Point of Care System for HbA1c

Preliminary Evaluation of a new Cystatin C Assay on the ABBOTT Clinical Chemistry Systems

Evaluation of SENTINEL CH. special assays on the ABBOTT c16000 Clinical Chemistry System

Evaluation of SENTINEL CH. Serum Protein Assays on Synchron LX Clinical Chemistry Sistem

Evaluation of MULTIGENT Creatinine (Enzymatic) Liquid on the ABBOTT Clinical Chemistry Systems